Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100054179Phase 4Completed
Phase 4, open-label, single-arm trial of Glycolic acid in acne vulgaris, sponsored by Beijing University of Chinese Medicine Shenzhen Hospital. Primary endpoints: Inflammatory lesions, Non-inflammatory lesions and 2 more. Started Apr 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100054179.